国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水

<span id="c0vjn"><table id="c0vjn"><thead id="c0vjn"></thead></table></span>

<small id="c0vjn"></small>

<menu id="c0vjn"><tt id="c0vjn"></tt></menu><menu id="c0vjn"><samp id="c0vjn"><i id="c0vjn"></i></samp></menu>

<label id="c0vjn"><tt id="c0vjn"></tt></label>

News Industry News Exhibition News Chemical Policy
Articles Trends Application Research Property History
Trades HOT RFQ TOP Suppliers
FAQ
Visit Guidechem
EN

Guideview > Ozempic

EU Confirms Vision Risk Tied to Semaglutide EMA EU regulators have confirmed a rare risk of vision loss linked to Novo Nordisk’s semaglutide, used in Wegovy and Ozempic. Drug labels will be updated to reflect the potential for NAION, a serious but very rare eye condition.
$1.09 Billion! Novo Nordisk Expands Production Capacity in Brazil Capacity Novo Nordisk is investing $1.09 billion to expand its Monte Mor facility in Brazil, focusing on Ozempic and Wegovy production. The project will create 500+ jobs by 2028.

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

小金县| 葫芦岛市| 兴安盟| 化德县| 离岛区| 中江县| 湖口县| 吴桥县| 丰原市| 来宾市| 抚顺市| 安宁市| 海林市| 乃东县| 芜湖市| 晋宁县| 木兰县| 儋州市| 怀仁县| 海南省| 隆尧县| 衡南县| 河津市| 修武县| 拉孜县| 宝应县| 修文县| 读书| 龙海市| 德阳市| 永年县| 高安市| 天峨县| 墨竹工卡县| 罗甸县| 涞水县| 开原市| 郎溪县| 韶山市| 蒲江县| 聂荣县|

<small id="xguey"><samp id="xguey"><rt id="xguey"></rt></samp></small>

<sup id="xguey"><samp id="xguey"><dl id="xguey"></dl></samp></sup>

<sup id="xguey"><tt id="xguey"><dl id="xguey"></dl></tt></sup>